CHEK2 and cancer: Here, we analyzed <i>CHEK2</i> in 129 TGCT cases unselected for age of onset, histology, clinical outcome, and family history of any cancer, and the frequency of identified variants was compared to findings in 27,173 ancestry-matched cancer-free men.